SOUTH SAN FRANCISCO, Calif.--Axys Pharmaceuticals here has promoted Alan Buckler to the position of vice-president for molecular genetics, from senior director for genomics. In the new job he will be responsible for all aspects of the company's molecular genetics program, including bioinformatics, genomics, genetics, and engineering, Axys said. Buckler will manage a staff of more than 100 at Axys's La Jolla, Calif., facility, which was formerly Sequana Therapeutics. Buckler was a founding member of Sequana's scientific advisory board.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.